Previous studies of the predictive role of the GALNT14-rs9679162 SNP showed that in HCC and esophageal cancer (“carcinoma”), patients with the “TT” genotype have a better prognosis, whereas in other cancers (“adenocarcinoma”), patients with the “GG” genotype have better outcomes [19,22,27,29,33,35,37]. This evidence concerns the gene GALNT14 and hepatocellular carcinoma.